As announced to the market on October 31, the Company has completed a share placement for 25,000,000 shares at $0.02 to raise a total of $500,000. It is planned that shareholders will be entitled to apply for new shares on the same terms as the placement, should the Company proceed with announcing a transaction.
Column 1 Column 2 Column 3 1 2
- 5.1 Bank balances
- 5.2 Call deposits
- 5.3 Bank overdrafts
- 5.4 Other (provide details)
- 5.5 Cash and cash equivalents at end of quarter (should equal item 4.6 above)
6 50 6 50 3 56 56
Column 1 Column 2 1 9. Estimated cash outflows for next quarter $A’000 2
- 9.1 Exploration and evaluation
- 9.2 Development
- 9.3 Production
- 9.4 Staff costs
- 9.5 Administration and corporate costs
- 9.6 Other (provide details if material)
- 9.7 Total estimated cash outflows
15
153 30
- Forums
- ASX - By Stock
- GML
- All Bad
All Bad
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GML (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.28M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 995940 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 995940 | 0.026 |
1 | 100000 | 0.024 |
1 | 100000 | 0.023 |
2 | 228000 | 0.021 |
2 | 1230000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 10000 | 1 |
0.028 | 214872 | 3 |
0.030 | 1881316 | 8 |
0.033 | 135691 | 2 |
0.035 | 318592 | 1 |
Last trade - 10.33am 13/11/2024 (20 minute delay) ? |
Featured News
GML (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online